Solaris Endovascular Inc. raised $5.0M in its first filing
Solaris Endovascular Inc. raised $5.0M in a seed round that began September 5, 2025. This is the first filing for the Texas biotechnology firm, which incorporated in 2024. All round types are estimates.
The filing from October 1, 2026, names Randolph Hubbell and Matthew Head as executive officers. Directors are Alexander Moreira, Melchiades Neto, Marco Costa, and David Stack.
We do not track its open roles yet.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2025-09-05 | $5.0M | Seed |
Named in the latest filing
- Randolph Hubbell
- Alexander Moreira
- Melchiades Neto
- Marco Costa
- David Stack
- Matthew Head
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR